Solid Biosciences Cash from Financing (Quarterly) Analysis

Solid Biosciences Inc (SLDB)

10.31 +0.77 (+8.07%) USD | NASDAQ | May 02, 14:56

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.505M
September 30, 2023	0.00
June 30, 2023	2.617M
March 31, 2023	0.00
December 31, 2022	74.74M
September 30, 2022	-0.001M
June 30, 2022	0.073M
March 31, 2022	0.022M
December 31, 2021	0.066M
September 30, 2021	0.003M
June 30, 2021	-0.238M
March 31, 2021	135.15M
December 31, 2020	128.70M
September 30, 2020	0.00

Date	Value
June 30, 2020	0.00
March 31, 2020	0.00
December 31, 2019	-0.287M
September 30, 2019	58.16M
June 30, 2019	0.00
March 31, 2019	0.00
December 31, 2018	-0.013M
September 30, 2018	0.00
June 30, 2018	-0.193M
March 31, 2018	131.71M
December 31, 2017	53.76M
September 30, 2017	-0.943M
June 30, 2017	-0.558M
March 31, 2017	24.82M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.287M

Minimum

Dec 2019

135.15M

Maximum

Mar 2021

21.03M

Average

0.003M

Median

Sep 2021

Cash from Financing (Quarterly) Benchmarks

Sarepta Therapeutics Inc	1.943M
PTC Therapeutics Inc	0.54M
Capricor Therapeutics Inc	23.17M
Perspective Therapeutics Inc	0.352M
Electromed Inc	0.026M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-20.82M
Cash from Investing (Quarterly)	45.30M
Free Cash Flow	-95.70M
Free Cash Flow Per Share (Quarterly)	-1.034
Free Cash Flow Yield	-46.69%